Patients with GCA or AAV were associated with an increased risk for hospitalization due to pneumonia compared with members of the general population.

In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

Eli Lilly has dominated headlines in recent months, recently taking the crown as the most valuable company in the biopharma industry by market cap. | Two investigational cardiometabolic drugs from Eli ...

Detailed price information for Avalo Therapeutics Inc (AVTX-Q) from The Globe and Mail including charting and trades.

A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...

Detailed price information for Coya Therapeutics Inc (COYA-Q) from The Globe and Mail including charting and trades.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...

NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, January 14, 2026. Let’s ...